Insights / Awards
Clinion Named Finalist at the SCDM 2025 Innovation Awards
Clinion has been named a finalist in the SCDM 2025 Innovation Awards for Clinical Data Science Implementation Excellence. The selection recognizes the breakthrough nature of our production-ready Multi-Agentic AI for Clinical Data Review, which is introducing a new level of intelligence and dependability to data operations across active clinical studies.
The Innovation That Won Recognition
Clinion’s Multi-Agentic AI for Data Review was developed to address long-standing inefficiencies in clinical data management, including slow review cycles, fragmented handoffs, rising data complexity, and the heavy operational load placed on Data Managers.
Our approach delivers something different: dependable, autonomous intelligence that strengthens data oversight without adding to operational effort. While most AI solutions still rely on prompts or extensive manual setup, this system confronts the core issue by introducing true autonomy into the data review process.
What Makes Clinion Stand Apart
Protocol-Aware Checks
The system interprets study logic directly from the protocol and CRF metadata, allowing it to propose review checks that reflect the actual design of the study. Data Managers simply review and approve, eliminating the need to build checks manually.
Contextual Discrepancy Detection
Instead of relying on static rules or threshold-based flags, the AI identifies issues using real protocol context. This ensures that only meaningful discrepancies surface, reducing noise and allowing teams to focus attention where it truly matters.
Smart Query Drafting Assistance
Queries are drafted automatically by the AI, based on real discrepancies detected during data review. Data Managers simply validate and release them, with full traceability and compliance.
Empowering Autonomy for Data Managers
The system prepares datasets, runs checks, and generates query drafts without requiring support from programming or biostatistics teams. Data Managers are freed to focus on strategic decision-making and oversight, elevating their role from operational execution to high-value management.
Proven Impact
Automation of query creation
Precision in identifying deviations
Cut in manual listing time
Why This Award Matters
The industry has reached a point where traditional review methods can no longer keep pace with data volume, complexity, or timelines. Clinion’s Multi-Agentic AI for Data Review offers a practical path forward by delivering automation that acts reliably, adapts to protocol context, and supports Data Managers by taking on routine tasks while maintaining accuracy and contextual understanding.
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance
Fully Compliant with Global Standards
